451 related articles for article (PubMed ID: 26980748)
41. The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.
Xu K; Tian X; Oh SY; Movassaghi M; Naber SP; Kuperwasser C; Buchsbaum RJ
Breast Cancer Res; 2016 Jan; 18(1):14. PubMed ID: 26821678
[TBL] [Abstract][Full Text] [Related]
42. Transcriptional Profiles and Stromal Changes Reveal Bone Marrow Adaptation to Early Breast Cancer in Association with Deregulated Circulating microRNAs.
Chiodoni C; Cancila V; Renzi TA; Perrone M; Tomirotti AM; Sangaletti S; Botti L; Dugo M; Milani M; Bongiovanni L; Marrale M; Tripodo C; Colombo MP
Cancer Res; 2020 Feb; 80(3):484-498. PubMed ID: 31776132
[TBL] [Abstract][Full Text] [Related]
43. Molecular profiling of microinvasive breast cancer microenvironment progression.
Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
[TBL] [Abstract][Full Text] [Related]
44. Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis.
Schneeberger VE; Allaj V; Gardner EE; Poirier JT; Rudin CM
PLoS One; 2016; 11(9):e0160587. PubMed ID: 27611664
[TBL] [Abstract][Full Text] [Related]
45. GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer.
Yang Z; Peng M; Cheng L; Jones K; Maihle NJ; Mivechi NF; Ko L
Am J Pathol; 2016 May; 186(5):1340-50. PubMed ID: 27001628
[TBL] [Abstract][Full Text] [Related]
46. Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces.
Sangaletti S; Iannelli F; Zanardi F; Cancila V; Portararo P; Botti L; Vacca D; Chiodoni C; Di Napoli A; Valenti C; Rizzello C; Vegliante MC; Pisati F; Gulino A; Ponzoni M; Colombo MP; Tripodo C
EBioMedicine; 2020 Nov; 61():103055. PubMed ID: 33096480
[TBL] [Abstract][Full Text] [Related]
47. RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model.
Jardim-Perassi BV; Alexandre PA; Sonehara NM; de Paula-Junior R; Reis Júnior O; Fukumasu H; Chammas R; Coutinho LL; Zuccari DAPC
Sci Rep; 2019 Jan; 9(1):966. PubMed ID: 30700756
[TBL] [Abstract][Full Text] [Related]
48. The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.
Nuzzo PV; Rubagotti A; Zinoli L; Salvi S; Boccardo S; Boccardo F
BMC Cancer; 2016 Feb; 16():95. PubMed ID: 26872609
[TBL] [Abstract][Full Text] [Related]
49. Integrated Bioinformatics Approach Reveals Crosstalk Between Tumor Stroma and Peripheral Blood Mononuclear Cells in Breast Cancer.
He L; Wang D; Wei N; Guo Z
Asian Pac J Cancer Prev; 2016; 17(3):1003-8. PubMed ID: 27039717
[TBL] [Abstract][Full Text] [Related]
50. Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays.
Shen K; Luk S; Hicks DF; Elman JS; Bohr S; Iwamoto Y; Murray R; Pena K; Wang F; Seker E; Weissleder R; Yarmush ML; Toner M; Sgroi D; Parekkadan B
Nat Commun; 2014 Dec; 5():5662. PubMed ID: 25489927
[TBL] [Abstract][Full Text] [Related]
51. Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.
Zhu K; Cai L; Cui C; de Los Toyos JR; Anastassiou D
PLoS Comput Biol; 2021 Jul; 17(7):e1009228. PubMed ID: 34283835
[TBL] [Abstract][Full Text] [Related]
52. Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes.
Ashida S; Orloff MS; Bebek G; Zhang L; Zheng P; Peehl DM; Eng C
Clin Cancer Res; 2012 Mar; 18(6):1578-87. PubMed ID: 22275508
[TBL] [Abstract][Full Text] [Related]
53. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice.
Jung M; Ryu YJ; Kang G
Pathol Res Pract; 2015 Dec; 211(12):925-30. PubMed ID: 26564105
[TBL] [Abstract][Full Text] [Related]
54. Malignant transformation of host stromal fibroblasts derived from the bone marrow traced in a dual-color fluorescence xenograft tumor model.
Dai X; Chen H; Chen Y; Wu J; Wang H; Shi J; Fei X; Wang Z; Wang A; Dong J; Lan Q; Huang Q
Oncol Rep; 2015 Dec; 34(6):2997-3006. PubMed ID: 26397840
[TBL] [Abstract][Full Text] [Related]
55. Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution.
Wallace JA; Li F; Leone G; Ostrowski MC
Cancer Res; 2011 Feb; 71(4):1203-7. PubMed ID: 21303970
[TBL] [Abstract][Full Text] [Related]
56. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.
Kim KT; Lee HW; Lee HO; Kim SC; Seo YJ; Chung W; Eum HH; Nam DH; Kim J; Joo KM; Park WY
Genome Biol; 2015 Jun; 16(1):127. PubMed ID: 26084335
[TBL] [Abstract][Full Text] [Related]
57. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M
J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000
[TBL] [Abstract][Full Text] [Related]
58. Cellular organization and molecular differentiation model of breast cancer-associated fibroblasts.
Busch S; Andersson D; Bom E; Walsh C; Ståhlberg A; Landberg G
Mol Cancer; 2017 Apr; 16(1):73. PubMed ID: 28372546
[TBL] [Abstract][Full Text] [Related]
59. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
Sotgia F; Martinez-Outschoorn UE; Pavlides S; Howell A; Pestell RG; Lisanti MP
Breast Cancer Res; 2011 Jul; 13(4):213. PubMed ID: 21867571
[TBL] [Abstract][Full Text] [Related]
60. Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior.
Scott MC; Tomiyasu H; Garbe JR; Cornax I; Amaya C; O'Sullivan MG; Subramanian S; Bryan BA; Modiano JF
Dis Model Mech; 2016 Dec; 9(12):1435-1444. PubMed ID: 27874835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
